Fleming Harold Edward — SEC Form 4 filings

SEC reporting owner CIK 1857250. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-05-31 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CRISPR Therapeutics AG (CRSP)Director33
Upstream Bio, Inc. (UPB)Director33
Sionna Therapeutics, Inc. (SION)Director22

Form 4 filings — Fleming Harold Edward

FiledFormIssuerReported transactionsSource
2026-06-184Sionna Therapeutics, Inc. (SION)Grant/award (A): 17,340 (derivative) @ $0EDGAR
2026-06-114Upstream Bio, Inc. (UPB)Grant/award (A): 17,096 (derivative) @ $0EDGAR
2026-06-094CRISPR Therapeutics AG (CRSP)Grant/award (A): 13,000 (derivative) @ $0EDGAR
2025-06-164Sionna Therapeutics, Inc. (SION)Grant/award (A): 19,959 (derivative) @ $0EDGAR
2025-06-124Upstream Bio, Inc. (UPB)Grant/award (A): 17,096 (derivative) @ $0EDGAR
2025-06-064CRISPR Therapeutics AG (CRSP)Grant/award (A): 13,000 (derivative) @ $0EDGAR
2024-10-154Upstream Bio, Inc. (UPB)Grant/award (A): 17,096 (derivative) @ $0EDGAR
2024-05-314CRISPR Therapeutics AG (CRSP)Grant/award (A): 13,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1857250 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →